Resolution pharmacology and the treatment of infectious
diseases
Vivian Vasconcelos Costa1*#, Filipe
Resende1*, Eliza Mathias Melo2,
Mauro Martins Teixeira2#
1Centro de Pesquisa e Desenvolvimento de Fármacos,
Department of Morphology, Institute of Biological Sciences, Universidade
Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
2 Centro de Pesquisa e Desenvolvimento de Fármacos,
Department of Biochemistry and Immunology, Institute of Biological
Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG,
Brazil.
*Both contributed equally to this work.
Author for correspondence:
#Mauro Martins Teixeira - Departamento de Bioquímica e Imunologia,
Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais.
Av. Antônio Carlos, 6627 - Pampulha - CEP 31270-901 - Belo Horizonte,
MG, Brasil. Phone #55 31 34096883.
E-mail:
mmtex.ufmg@gmail.com /
mmtex@icb.ufmg.br
#Vivian Vasconcelos Costa – Departamento de Morfologia, Instituto de
Ciências Biológicas, Universidade Federal de Minas Gerais. Av. Antônio
Carlos, 6627 - Pampulha - CEP 31270-901 - Belo Horizonte, MG, Brasil.
Phone #55 31 34093082.
E-mail:
vivianvcosta@gmail.com/
vivianvcosta@ufmg.br
Word count: 7418
Acknowledgements: The authors thank L’Oréal-UNESCO-ABC ‘Para
Mulheres na Ciência’ prize granted to VVC, and the PhD scholarship
provided by CAPES to F.R., under project process 88881.507175/2020-01.
Financial support: This work received financial support from
the National Institute of Science and Technology in Dengue and
Host-microorganism Interaction (INCT dengue), a program funded by The
Brazilian National Science Council (CNPq, Brazil process 465425/2014-3)
and Minas Gerais Foundation for Science (FAPEMIG, Brazil process
25036/2014-3) and from Rede de Pesquisa em Imunobiológicos e Biofármacos
para terapias avançadas e inovadoras (ImunoBioFar), provided by FAPEMIG
under process RED-00202-22” 29568-1 and FAPEMIG process APQ-02281-18.
This study was also financed in part by the Coordenação de
Aperfeiçoamento de Pessoal de Nível Superior (CAPES, Brazil), process
88881.507175/2020-01.
Conflict of interest statement: No competing interests
declared.